QMCO:NASDAQQuantum Corporation Analysis
Data as of 2026-06-17 - not real-time
$14.95
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Quantum Corporation is trading in a bullish technical environment, with the 20‑day moving average comfortably above both the 50‑day and 200‑day averages, a MACD histogram that remains positive and an RSI hovering in the upper‑mid range, suggesting continued upward momentum.
However, the fundamentals tell a cautionary story: the company reports negative earnings, a negative price‑to‑earnings multiple and a book value per share that is below zero, while its balance sheet shows debt that vastly exceeds cash. Recent news of an equity financing round aimed at strengthening the balance sheet and the filing of a late‑reporting notice adds short‑term uncertainty, but the technical setup and a price‑to‑sales multiple below one imply that the market may be undervaluing the stock’s growth potential in AI‑driven storage solutions.
However, the fundamentals tell a cautionary story: the company reports negative earnings, a negative price‑to‑earnings multiple and a book value per share that is below zero, while its balance sheet shows debt that vastly exceeds cash. Recent news of an equity financing round aimed at strengthening the balance sheet and the filing of a late‑reporting notice adds short‑term uncertainty, but the technical setup and a price‑to‑sales multiple below one imply that the market may be undervaluing the stock’s growth potential in AI‑driven storage solutions.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Bullish technical indicators (price above key moving averages, positive MACD)
- Increasing trading volume supporting momentum
- Equity infusion expected to improve near‑term balance‑sheet flexibility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Potential upside to the 18.5 % resistance level
- Strategic positioning in AI‑enabled storage markets
- Undervalued price relative to sales and industry peers
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Persistent profitability challenges and high leverage
- Elevated beta and extreme volatility indicating price swings
- Dependence on successful execution of turnaround initiatives
Key Metrics & Analysis
Financial Health
Revenue Growth8.60%
Profit Margin-37.76%
P/E Ratio-42.1
ROA-9.94%
P/B Ratio-1.1
Op. Cash Flow$-40706000
Free Cash Flow$-38030376
Industry P/E37.0
Technical Analysis
TrendBullish
RSI68.7
Support$7.78
Resistance$18.48
MA 20$11.95
MA 50$9.35
MA 200$8.08
MACDBullish
VolumeIncreasing
Fear & Greed Index88.5
Valuation
Target Price$16.50
Upside/Downside10.37%
GradeUndervalued
TypeBlend
Risk Assessment
Beta3.56
Volatility143.00%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.